Medipharm Labs Corp (LABS) - Total Liabilities

Latest as of March 2026: CA$8.52 Million CAD ≈ $6.16 Million USD

Based on the latest financial reports, Medipharm Labs Corp (LABS) has total liabilities worth CA$8.52 Million CAD (≈ $6.16 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Medipharm Labs Corp's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Medipharm Labs Corp - Total Liabilities Trend (2016–2025)

This chart illustrates how Medipharm Labs Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Medipharm Labs Corp asset portfolio.

Medipharm Labs Corp Competitors by Total Liabilities

The table below lists competitors of Medipharm Labs Corp ranked by their total liabilities.

Company	Country	Total Liabilities
MESB Bhd KLSE:7234	Malaysia	RM66.07 Million
Rimfire Pacific Mining Ltd AU:RIM	Australia	AU$2.31 Million
ALUMEXX N.V. NAM. EO-10 F:NE8F	Germany	€32.15 Million
Eastparc Hotel Tbk PT JK:EAST	Indonesia	Rp24.07 Billion
GeneMatrix Inc KQ:109820	Korea	₩9.72 Billion
VRX Silica Ltd AU:VRX	Australia	AU$761.02K
AJ Advance Technology Public Company Limited BK:AJA	Thailand	฿98.67 Million
BMS Celik Hasir Sanayi ve Ticaret AS IS:BMSCH	Turkey	TL869.65 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Medipharm Labs Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See LABS equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medipharm Labs Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medipharm Labs Corp (2016–2025)

The table below shows the annual total liabilities of Medipharm Labs Corp from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CA$9.93 Million ≈ $7.18 Million	-5.88%
2024-12-31	CA$10.55 Million ≈ $7.63 Million	-3.53%
2023-12-31	CA$10.93 Million ≈ $7.91 Million	+15.19%
2022-12-31	CA$9.49 Million ≈ $6.86 Million	+2.98%
2021-12-31	CA$9.21 Million ≈ $6.67 Million	-76.86%
2020-12-31	CA$39.82 Million ≈ $28.80 Million	+5.89%
2019-12-31	CA$37.60 Million ≈ $27.20 Million	+152.61%
2018-12-31	CA$14.89 Million ≈ $10.77 Million	+489.78%
2017-12-31	CA$2.52 Million ≈ $1.83 Million	+5301.70%
2016-12-31	CA$46.73K ≈ $33.80K	--

About Medipharm Labs Corp

TO:LABS Canada Drug Manufacturers - Specialty & Generic

Market Cap

$21.51 Million

CA$29.74 Million CAD

Market Cap Rank

#24972 Global

#969 in Canada

Share Price

CA$0.07

Change (1 day)

+0.00%

52-Week Range

CA$0.06 - CA$0.09

All Time High

CA$7.17